Ji, X.; Meng, X.; He, Q.; Xiang, X.; Shi, Y.; Zhu, X.
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. Int. J. Mol. Sci. 2023, 24, 757.
https://doi.org/10.3390/ijms24010757
AMA Style
Ji X, Meng X, He Q, Xiang X, Shi Y, Zhu X.
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International Journal of Molecular Sciences. 2023; 24(1):757.
https://doi.org/10.3390/ijms24010757
Chicago/Turabian Style
Ji, Xiwei, Xiangrui Meng, Qingfeng He, Xiaoqiang Xiang, Yufei Shi, and Xiao Zhu.
2023. "Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling" International Journal of Molecular Sciences 24, no. 1: 757.
https://doi.org/10.3390/ijms24010757
APA Style
Ji, X., Meng, X., He, Q., Xiang, X., Shi, Y., & Zhu, X.
(2023). Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International Journal of Molecular Sciences, 24(1), 757.
https://doi.org/10.3390/ijms24010757